Quantcast

Latest Reference standard Stories

2012-08-02 23:02:49

Protection of Global Heparin Supply Focus of International Meeting Rockville, Md (PRWEB) August 02, 2012 As part of its role in ongoing efforts to better safeguard the global supply of medicines, the U.S. Pharmacopeial Convention (USP) will co-host the “Fifth Workshop on the Characterization of Heparin Products” at its U.S. headquarters in Rockville, Md., August 14-15, 2012. Since 2008, USP´s workshop on heparin products has provided a forum for manufacturers, regulators...

2012-05-23 20:48:42

Detection procedures, acceptable limits for testing established by USP As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters <232> Elemental Impurities–Limits and <233> Elemental Impurities–Procedures. The new standards provide procedures for the detection of selected impurities in drug products based on modern analytical...

2012-04-10 23:01:55

USP Board Paves the Way for Center in Ghana for Pharmaceutical Training in Sub-Saharan Africa Rockville, MD (PRWEB) April 09, 2012 The threat of counterfeit and substandard medicines is a problem that not only affects developing countries, but has repercussions felt around the world. Expanding upon its long-standing commitment to improving the quality of all medicines, the United States Pharmacopeial Convention (USP) has increased its philanthropic outreach with the proposed creation of a...

2012-03-28 23:03:41

Organization Expanding Global Public Health Work with Focus on Substandard, Falsified and Counterfeit Medicines in Developing Countries (PRWEB) March 28, 2012 As it expands its work in the area of global public health with a focus on substandard, falsified and counterfeit medicines, the U.S. Pharmacopeial Convention (USP) recently was invited to create a Commitment to Action as a member of the Clinton Global Initiative (CGI). Established in 2005 by President Bill Clinton, CGI convenes...

2011-09-06 18:30:00

Product Class Quality, Bioassays, Regulatory Issues Related to Monoclonal Antibodies, Cell Therapies, and Other Biologics to Be Addressed Rockville, MD (PRWEB) September 06, 2011 Increasingly used to treat certain advanced-stage cancers, chronic inflammatory diseases, and complex disorders such as cystic fibrosis, biologic and biotechnology products are providing answers to some of the unmet needs for a growing list of diseases. Collectively referred to as...

2011-02-09 00:01:26

May Pave the Way for Expanded Support to Developing Countries Rockville, MD (Vocus/PRWEB) February 08, 2011 Recognizing the vital importance of quality-assured medicines to patients and healthcare providers, the U.S. Pharmacopeial Convention (USP) today announced it has launched a pilot Technical Assistance Program (TAP) to provide developing countries with greater capacity to test the quality of medicines. Under the TAP, participating countries will receive a comprehensive package of...

2010-11-10 17:22:09

National Institute of Standards and Technology (NIST) researchers have developed new certified reference materials for measuring amounts of organic acids in dietary supplements formulated with Vaccinium berries"”cranberries, blueberries and bilberries. As described in a recent paper,* manufacturers and researchers can use this new suite of standard reference materialsTM (SRMs) as quality assurance tools. berry SRMs Dietary supplement manufacturers often include health claims on products...

2009-11-18 15:43:51

Materials advance state-of-the-art pharmaceutical testing, respond to needs of in-vitro drug device industry To help bring greater certainty to the measurement of medication levels in a patient's bloodstream for three drugs with narrow therapeutic ranges, the U.S. Pharmacopeial Convention (USP) is releasing new certified reference materials (CRMs). The three new CRMs are for carbamazepine, an anticonvulsant and mood stabilizing drug used primarily in the treatment of epilepsy and bipolar...

2009-10-01 12:55:47

The U.S. Food and Drug Administration says a change in heparin manufacturing controls will reduce the blood-thinning drug's potency. To ensure the quality of heparin and to guard against potential contamination, the United States Pharmacopeia -- a non-profit standards-setting organization -- adopted new manufacturing controls for heparin, the FDA said in a statement. These changes include a modification of the reference standard for the drug's unit dose. In an alert issued to healthcare...

2009-10-01 12:25:00

Adjustments may be needed to achieve desired anticoagulant effect in some patients New Heparin to Ship Starting October 8 SILVER SPRING, Md., Oct. 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today alerted health care professionals to a change in heparin manufacturing that is expected to decrease the potency of the common blood-clotting drug. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) To ensure the quality of heparin and to guard against...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.